SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-012328
Filing Date
2020-05-14
Accepted
2020-05-14 17:14:57
Documents
47
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_adialpharma.htm 10-Q 354254
2 CERTIFICATION f10qex31-1_adialpharma.htm EX-31.1 12141
3 CERTIFICATION f10qex31-2_adialpharma.htm EX-31.2 12140
4 CERTIFICATION f10qex32-1_adialpharma.htm EX-32.1 3878
5 CERTIFICATION f10qex32-2_adialpharma.htm EX-32.2 3926
12 GRAPHIC img_001.jpg GRAPHIC 108341
  Complete submission text file 0001213900-20-012328.txt   2418133

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE adil-20200331.xml EX-101.INS 297345
7 XBRL SCHEMA FILE adil-20200331.xsd EX-101.SCH 40318
8 XBRL CALCULATION FILE adil-20200331_cal.xml EX-101.CAL 28896
9 XBRL DEFINITION FILE adil-20200331_def.xml EX-101.DEF 125818
10 XBRL LABEL FILE adil-20200331_lab.xml EX-101.LAB 255061
11 XBRL PRESENTATION FILE adil-20200331_pre.xml EX-101.PRE 189127
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 20878957
SIC: 2834 Pharmaceutical Preparations